pharma news today glp-1 obesity drugs today π The next trillion-dollar drug war has begun Drugmakers including Eli Lilly, Novo Nordisk, Pfizer, Amgen, AstraZeneca and others are racing beyond today's drugs. New pills, monthly injections and next-generation GLP-1 Drug Market: the rapid
Description
Some evidence suggests allulose may improve insulin sensitivity and reduce postprandial glucose spikes, independent of GLP-1 activation
FDA cleared its Phase 1 Investigational New Drug application on June 23, 2026
Acquisition, analysis, or interpretation of data: H.J.C., M.A.N., J.H.M
Development and characterisation of a novel glucagon like peptide-1 receptor antibody
If you dont sleep well, it can mess up your hormones, including GLP-1
We will begin with an amuse-bouche of GI physiology, incretin biology and diabetes
